Association between XRCC1 and XRCC3 Polymorphisms with Lung Cancer Risk: A Meta-Analysis from Case-Control Studies

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Huang, Guohua ^a   Cai, Shaoxi ^a   Wang, Wei ^b,c,d   Zhang, Qing ^a   Liu, Aihua ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b ZHUHAI PEOPLE S HOSPITAL ZHUHAI HOSPITAL AFFILIATED WITH JINAN UNIVERSITY   (China)

^c Beijing Zhendong Guangming Pharmaceutical Institute   (China)

^d Shanxi Zhendong Pharmaceutical Co Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

XRCC1 PROTEIN; XRCC3 PROTEIN;

ARTICLE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; ETHNICITY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENOTYPE; HOSPITAL; HUMAN; INHERITANCE; LUNG CANCER; SENSITIVITY ANALYSIS; XRCC1 GENE; XRCC3 GENE;

CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK; RISK FACTORS;

EID: 84883154306     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068457     Document Type: Article

References (100)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Tardon A, Lee WJ, Delgado-Rodriguez M, Dosemeci M, Albanes D, et al. (2005) Leisure-time physical activity and lung cancer: a meta-analysis. Cancer Causes Control 16: 389-97.
3. Rodriguez V, Tardon A, Kogevinas M, Prieto CS, Cueto A, et al. (2000) Lung cancer risk in iron and steel foundry workers: a nested case-control study in Asturias, Spain. Am J Ind Me 38: 644-50.
4. Spitz MR, Wei Q, Dong Q, Amos CI, Wu X, (2003) Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev 12: 689-98.
5. Vispe S, Yung TM, Ritchot J, Serizawa H, Satoh MS, (2000) A cellular defense pathway regulating transcription through poly (ADPribosyl) ation in response to DNA damage. Proc Natl Acad Sci U S A 97: 9886-91.
6. Hoeijmakers JH, (2001) Genome maintenance mechanisms for preventing cancer. Nature 411: 366-74.
7. Wei Q, Cheng L, Hong WK, Spitz MR, (1996) Reduced DNA repair capacity in lung cancer patients,. Cancer Res 56: 4103-7.
8. Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, et al. (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 92: 1764-72.
9. Shen H, Spitz MR, Qiao Y, Guo Z, Wang LE, et al. (2003) Smoking, DNA repair capacity and risk of non-small cell lung cancer. Int J Cancer 107: 84-88.
10. Xi T, Jones IM, Mohrenweiser HW, (2004) Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics 83: 970-9.
11. Yu Z, Chen J, Ford BN, Brackley ME, Glickman BW, (1999) Human DNA repair systems: an overview. Environ Mol Mutagen 33: 3-20.
12. Wood RD, Mitchell M, Sgouros J, Lindahl T, (2001) Human DNA repair genes. Science 291: 1284-9.
13. Vidal AE, Boiteux S, Hickson AD, Radicella JP, (2001) XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions,. EMBO J 20: 6530-9.
14. Lu AL, Li XH, Gu YS, Wright PM, Chang DY, (2001) Repair of oxidative DNA damage-mechanisms and functions,Cell Biochem. Biophys 35: 141-70.
15. Kubota Y, Nash RA, Klungland A, Schär P, Barnes DE, et al. (1996) Resconstitution of DNA base excision repair with purified human proteins: Interaction between DNA polymerase beta and the XRCC1 protein. EMBO J 15: 6662-70.
16. Shen MR, Jones IM, Mohrenweiser H, (1998) No conservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58: 604-8.
17. Shin A, Lee KM, Ahn B, Park CG, Noh SK, et al. (2008) Genotype-phenotype relationship between DNA repair gene genetic polymorphisms and DNA repair capacity. Asian Pac J Cancer Prev 9: 501-5.
18. Tebbs RS, Zhao Y, Tucker JD, Scheerer JB, Siciliano MJ, et al. (1995) Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc Natl Acad Sci USA 92: 6354-8.
19. Thacker J, Zdzienicka MZ, (2004) The XRCC genes: expanding roles in DNA double-strand break repair. DNARepair (Amst.) 3: 1081-90.
20. Matullo G, Palli D, Peluso M, Guarrera S, Carturan S, et al. (2001) XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects. Carcinogenesis 22: 1437-45.
21. Ward J, (1988) DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation and reparability. Prog Nucleic Acids Res Mol Biol 35: 95-125.
22. Mohrenweiser H, Wilson D, Jones I, (2003) Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat Res 526: 93-125.
23. Goode E, Ulrich C, Potter J, (2002) Polymorphisms in DNA repairs genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11: 1513-30.
24. Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, et al. (2002) Variants in double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11: 1399-440.
25. Ratnasinghe D, Yao SX, Tangrea JA, Qiao YL, Andersen MR, et al. (2001) Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 10: 119-23.
26. David-Beabes GL, London SJ, (2001) Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians. Lung Cancer 34: 333-9.
27. David-Beabes GL, Lunn RM, London SJ, (2001) No association between the XPD (Lys751G1n) polymorphism and the XRCC3 (Thr241Met) polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 10: 911-2.
28. Divine KK, Gilliland FD, Crowell RE, Stidley CA, Bocklage TJ, et al. (2001) The XRCC1 399 glutamine allele is a risk factor for adenocarcinoma of the lung. Mutat Res 461: 273-8.
29. Chen S, Tang D, Xue K, Xu L, Ma G, et al. (2002) DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis 23: 1321-5.
30. Park JY, Lee SY, Jeon HS, Bae NC, Chae SC, et al. (2002) Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 11: 23-7.
31. Misra RR, Ratnasinghe D, Tangrea JA, Virtamo J, Andersen MR, et al. (2003) Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett 191: 171-8.
32. Ratnasinghe DL, Yao SX, Forman M, Qiao YL, Andersen MR, et al. (2003) Gene-environment interactions between the codon 194 polymorphism of XRCC1 and antioxidants influence lung cancer risk. Anticancer Res 23: 627-32.
33. Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, et al. (2004) Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 12: 359-65.
34. Wang Y, Liang D, Spitz MR, Zhang K, Dong Q, et al. (2003) XRCC3 genetic polymorphism, smoking, and lung carcinoma risk in minority populations. Cancer 98: 1701-6.
35. Ito H, Matsuo K, Hamajima N, Mitsudomi T, Sugiura T, et al. (2004) Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk. Carcinogenesis 25: 1395-401.
36. Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, et al. (2004) Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer. Carcinogenesis 25: 2433-41.
37. Liu G, Zhou W, Park S, Wang LI, Miller DP, et al. (2004) The SOD2 Val/Val genotype enhances the risk of non-small cell lung carcinoma by p53 and XRCC1 polymorphisms,. Cancer 101: 2802-8.
38. Harms C, Salama SA, Sierra-Torres CH, Cajas-Salazar N, Au WW, (2004) Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer. Environ Mol Mutagen 44: 74-82.
39. Jacobsen NR, Raaschou-Nielsen O, Nexø B, Wallin H, Overvad K, et al. (2004) XRCC3 polymorphisms and risk of lung cancer. Cancer Lett 213: 67-72.
40. Zhang X, Miao X, Liang G, Hao B, Wang Y, et al. (2005) Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res 65: 722-6.
41. Hung RJ, Brennan P, Canzian F, Szeszenia-Dabrowska N, Zaridze D, et al. (2005) Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 97: 567-76.
42. Vogel U, Nexo BA, Wallin H, Overvad K, Tjonneland A, et al. (2004) No association between base excision repair gene polymorphisms and risk of lung cancer. Biochem Genet 42: 453-60.
43. Schneider J, Classen V, Bernges U, Philipp M, (2005) XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking. Int J Mol Med 16: 709-16.
44. Shen M, Berndt SI, Rothman N, Mumford JL, He X, et al. (2005) Polymorphisms in the DNA base excision repair genes APEX1 and XRCC1 and lung cancer risk in Xuan Wei, China. Anticancer Res 25: 537-42.
45. Chan EC, Lam SY, Fu KH, Kwong YL, (2005) Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes. Cancer Genet Cytogenet 162: 10-20.
46. Li M, Yin Z, Cui Z, He Q, Zhou B, (2005) Association of genetic polymorphism in DNA repair gene XRCC1 with risk of lung adenocarcinoma in nonsmoking women, Chinese J. Lung Cancer 8: 431-4.
47. Hu Z, Ma H, Lu D, Zhou J, Chen Y, et al. (2005) A promoter polymorphism (-77T>C) of DNA repair gene XRCC1 is associated with risk of lung cancer in relation to tobacco smoking. Pharmacogenet Genomics 15: 457-63.
48. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, et al. (2006) Polymorphisms of DNA repair genes and risk of nonsmall cell lung cancer. Carcinogenesis 27: 560-7.
49. Matullo G, Dunning AM, Guarrera S, Baynes C, Polidoro S, et al. (2006) DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 27: 997-1007.
50. Hao B, Miao X, Li Y, Zhang X, Sun T, et al. (2006) A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene 25: 3613-20.
51. Landi S, Gemignani F, Canzian F, Gaborieau V, Barale R, et al. (2006) DNA repair and cell cycle control genes and the risk of young-onset lung cancer. Cancer Res 66: 11062-9.
52. Ryk C, Kumar R, Thirumaran RK, Hou SM, (2006) Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers. Lung cancer 54: 285-92.
53. De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, et al. (2007) Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat Res 631: 101-10.
54. Pachouri SS, Sobti RC, Kaur P, Singh J, (2007) Contrasting impact of DNA repair gene XRCC1 polymorphisms Arg399Gln and Arg194Trp on the risk of lung cancer in the north-Indian population. DNA Cell Biol 26: 186-91.
55. Yin J, Vogel U, Ma Y, Qi R, Sun Z, et al. (2007) The DNA repair gene XRCC1 and genetic susceptibility of lung cancer in a northeastern Chinese population. Lung Cancer 56: 153-60.
56. López-Cima MF, González-Arriaga P, García-Castro L, Pascual T, Marrón MG, et al. (2007) Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain,. BMC Cancer 7: 162.
57. Zhang ZL, Zhou CC, Zhang J, Tang L, Su B, (2007) Relationship between polymorphisms of DNA repair gene XRCC3 and susceptibility to lung cancer. Zhonghua Jie He He Hu Xi Za Zhi 30: 936-40.
58. Improta G, Sgambato A, Bianchino G, Zupa A, Grieco V, et al. (2008) Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population. Anticancer Res 28: 2941-6.
59. Li M, Yin Z, Guan P, Li X, Cui Z, et al. (2008) XRCC1 polymorphisms, cooking oil fume and lung cancer in Chinese women nonsmokers. Lung Cancer 62: 145-51.
60. Yin J, Vogel U, Ma Y, Qi R, Wang H, (2013) Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women. Cancer Genet Cytogenet 188: 26-31.
61. Hsieh WC, Cheng YW, Lin CJ, Chou MC, Chen CY, et al. (2009) Prognostic significance of X-ray cross-complementing group 1 T-77C polymorphism in resected non-small cell lung cancer. Jpn J Clin Oncol 39: 81-5.
62. Cote ML, Yoo W, Wenzlaff AS, Prysak GM, Santer SK, et al. (2009) Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis 30: 626-35.
63. Qian B, Zhang H, Zhang L, Zhou X, Yu H, et al. (2011) Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer 73: 138-46.
64. Tanaka Y, Maniwa Y, Bermudez VP, Doi T, Nishio W, et al. (2010) Nonsynonymous single nucleotide polymorphisms in DNA damage repair pathways and lung cancer risk. Cancer 116: 896-902.
65. Kim IS, Lee GW, Kim DC, Kim HG, Kim S, et al. (2010) Polymorphisms and haplotypes in the XRCC1 gene and the risk of advanced non-small cell lung cancer. J Thorac Oncol 5: 1912-21.
66. Osawa K, Miyaishi A, Uchino K, Osawa Y, Inoue N, et al. (2010) APEX1 Asp148Glu gene polymorphism is a risk factor for lung cancer in relation to smoking in Japanese. Asian Pac J Cancer Prev 11: 1181-6.
67. Huang M, Chen X, Qiu Y, Fan L, Chen J, et al. (2011) Relationship between XRCC3 gene polymorphisms and lung cancer. Wei Sheng Yan Jiu 40: 187-90.
68. Janik J, Swoboda M, Janowska B, Cieśla JM, Gackowski D, et al. (2011) 8-Oxoguanine incision activity is impaired in lung tissues of NSCLC patients with the polymorphism of OGG1 and XRCC1 genes. Mutat Res 709-710: 21-31.
69. Li Z, Guan W, Li MX, Zhong ZY, Qian CY, et al. (2011) Genetic polymorphism of DNA base-excision repair genes (APE1, OGG1 and XRCC1) and their correlation with risk of lung cancer in a Chinese population. Arch Med Res 42: 226-34.
70. Wang N, Wu Y, Zhou X, Wu Y, (2013) Association between genetic polymorphism of metabolizing enzymes and DNA repairing enzymes and the susceptibility of lung cancer in Henan population. Wei Sheng Yan Jiu 41: 251-6.
71. Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y, (2012) Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population. J Thorac Oncol 7: 954-62.
72. Sreeja L, Syamala VS, Syamala V, Hariharan S, Raveendran PB, et al. (2008) Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J Cancer Res Clin Oncol 134 (6) (): 645-52.
73. Chang JS, Wrensch MR, Hansen HM, Sison JD, Aldrich MC, et al. (2009) Base excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African-Americans. Carcinogenesis 30 (1) (): 78-87.
74. Davey SG, Egger M, (1997) Meta-analyses of randomized controlled trials. Lancet 350: 1182.
75. Ioannidis JP, Boffetta P, Little J, O'Brien TR, Uitterlinden AG, et al. (2008) Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol 37: 120-32.
76. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. Natl Cancer Inst 22: 719-78.
77. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-88.
78. Wang D, Lippard SJ, (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4: 307-320.
79. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-101.
80. Egger M, Smith DG, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-34.
81. Kiyohara K, Takayama K, Nakanishi Y, (2006) Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis,. Lung Cancer 54: 267-83.
82. Wang Y, Yang H, Li H, Li L, Wang H, et al. (2009) Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis. Cancer Lett 285: 134-40.
83. Dai L, Duan F, Wang P, Song C, Wang K, et al. (2012) XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep 39: 9535-47.
84. Sun H, Qiao Y, Zhang X, Xu L, Jia X, et al. (2010) XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: a meta-analysis. Cancer Sci 101: 1777-82.
85. Zhan P, Wang Q, Qian Q, Yu LK, (2013) XRCC3 Thr241Met gene polymorphisms and lung cancer risk: a meta-analysis. J Exp Clin Cancer Res 32 (1) (): 1.
86. Xu YH, Gu LP, Sun YJ, Cheng BJ, Lu S, (2013) No significant association between the XRCC3 Thr241Met polymorphism and lung cancer risk: a meta-analysis. Tumour Biol [Epub ahead of print].
87. Lengauer C, Kinzler KW, Vogelstein B, (1998) Genetic instabilities in human cancers. Nature 396: 643-649.
88. Sia EA, Kokoska RJ, Dominska M, Greenwell P, Petes TD, (1997) Microsatellite instability in yeast: dependence on repeat unit size and DNA mismatch repair genes. Mol Cell Biol 17: 2851-2858.
89. Aquilina G, Bignami M, (2001) Mismatch repair in correction of replication errors and processing of DNA damage. J Cell Physiol 187: 145-154.
90. Tomescu D, Kavanagh G, Ha T, Campbell H, Melton DW, (2001) Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis 22: 403-408.
91. Wang D, Lippard SJ, (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4: 307-320.
92. Stoehlmacher J, Ghaderi V, Iobal S, Groshen S, Tsao-Wei D, et al. (2001) A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer. Anticancer Res 21: 3075-3079.
93. De Ruyck K, Van Eijkeren M, Claes K, Morthier R, De Paepe A, et al. (2005) Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes. Int J Radiat Oncol Biol Phys 62: 1140-1149.
94. Sak SC, Harnden P, Johnston CF, Paul AB, Kiltie AE, (2005) APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer. Clin Cancer Res 11: 6205-6211.
95. Caldecott KW, McKeown CK, Tucker JD, Ljungquist S, Thompson LH, (1994) An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol Cell Biol 14 (1) (): 68-76.
96. Higgins JPT, Green S (2008) Cochrane handbook for systematic reviews of interventions version 5.0.1. The Cochrane Collaboration, Oxford.
97. Vineis P, Manuguerra M, Kavvoura FK, Guarrera S, Allione A, et al. (2005) A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst 101 (1) (): 24-36.
98. Liu L, Yuan P, Liu L, Wu C, Zhang X, et al. (2011) A functional -77T>C polymorphism in XRCC1 is associated with risk of breast cancer. Breast Cancer Res Treat 125 (2) (): 479-87.
99. Liu L, Yuan P, Wu C, Zhang X, Wang F, et al. (2011) Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer 73 (1) (): 110-5.
100. Liu L, Wu J, Zhong R, Wu C, Zou L, et al. (2012) Multi-loci analysis reveals the importance of genetic variations in sensitivity of platinum-based chemotherapy in non-small-cell lung cancer. Mol Carcinog doi: 10.1002/mc.21942.